Monopar Therapeutics Inc. (MNPR)
Market Closed
17 Jul, 20:00
$
111. 12
+2.6
+2.3959%
$
714.12M Market Cap
- P/E Ratio
- Div Yield
265,200 Volume
-0.65 Eps
$ 108.52
Previous Close 
Want to track MNPR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Monopar Therapeutics Inc. (MNPR) Statistics
Valuation metrics
Market Cap 714.12M
Enterprise value 691.99M
Trailing P/E (ttm) -53.68
Forward P/E -14.52
PEG ratio 1.9
Price/Sales (ttm) -
Price/Book (mrq) 7
Enterprise Value/Revenue -
Enterprise Value/EBITDA -44.24
Overview
Shares outstanding 6.69M
Float 4.4M
Shares short 1.68M
% Held by insiders 0.24%
% Held by institutions 0.83%
Average volume (10 days) 264.76K
Average volume (90 days) 183.27K
Price summary
52-Week low 29.18
52-Week high 112.57
Beta 1.66
50-Day moving average 80.43
200-Day moving average 60.74
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 13 Aug 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.11%
Return on equity -0.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -13.72M
Diluted EPS (ttm) -1.76
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 140.4M
Total cash per share (mrq) 16.11
Total debt (mrq) 245.49K
Total Debt/Equity (mrq) 0
Current ratio (mrq) 56.04%
Book value per share (mrq) 15.86
Cash Flow
Cash flow statement -12.2M
Levered free cash flow (LFCF) -8.2M
